In this study, patients were screened for the HLA-B 15:02 allele before the initiation of carbamazepine treatment, and it was found that withholding carbamazepine from HLA-B 15:02-positive subjects reduced the incidence of SJS–TEN [34]. The gene discussed is HLA-B; the disease is toxic epidermal necrolysis.